BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Business

  Adolor Corporation Reports Second Quarter 2008 Financial Results

  August 6, 2008

   · 

  1 min read
• Business

  Dyax Corp. Enters into $50 Million Agreement with Cowen Healthcare Royalty Partners

  August 6, 2008

   · 

  6 min read
• BioMidwest

  ChanTest, Inc. Launches New Business to Provide Validated Ion Channel Expressing Cell Lines to the Research Community

  August 6, 2008

   · 

  3 min read
• Drug Development

  Tolerx, Inc. Initiates Dosing of Otelixizumab, a Novel Type 1 Diabetes Agent, in DEFEND, a Phase 3 Clinical Trial Milestone Achievement Triggers $15 Million Payment from Collaborator GlaxoSmithKline (JOBS)

  August 6, 2008

   · 

  6 min read
• Business

  BioMarin Pharmaceutical Inc. Announces Second Quarter 2008 Financial Results

  August 6, 2008

   · 

  9 min read
• Policy

  Tecan Infinite(R) M1000 and Infinite F500 Multimode Readers are Granted LanthaScreen(TM) Certified Plus Status by Invitrogen Corporation

  August 6, 2008

   · 

  2 min read
• Business

  Genomic Health, Inc. Announces Second Quarter 2008 Financial Results and Business Progress

  August 6, 2008

   · 

  7 min read
• Business

  Ariad Pharmaceuticals, Inc. to Receive $2.5 Million from Partner Merck & Co., Inc.

  August 6, 2008

   · 

  1 min read
• BioMidwest

  Terumo Heart Inc. Announces First DuraHeart(TM) Left Ventricular Assist System Implanted in the U.S. Pivotal Trial

  August 6, 2008

   · 

  2 min read
• Business

  Vanda Pharmaceuticals, Inc. Reports Second Quarter 2008 Results

  August 6, 2008

   · 

  8 min read